Overview

Metoclopramide Pilot Trial

Status:
Terminated
Trial end date:
2019-12-12
Target enrollment:
Participant gender:
Summary
Infants with gastroschisis typically have poor intestinal motility for the first weeks to months after birth. Prokinetic agents are often used in these infants to improve intestinal motility in an attempt to quicken the attainment of enteric feeds. However, the evidence to support this practice remains weak. Investigators hypothesize that a prokinetic agent given intravenously (infused into a vein) may be effective in improving gut motility in children with gastroschisis.
Phase:
Phase 3
Details
Lead Sponsor:
The Hospital for Sick Children
Collaborator:
The Physicians' Services Incorporated Foundation
Treatments:
Metoclopramide